Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comfortage - Integration of Biomarkers, Genetic and Clinical Risk Factors for AD Prevention Strategies
NCT06896201Active, not recruiting
- Sponsor
- Policlinico Gemelli
- Start
- Oct 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Policlinico Gemelli. Primary endpoints: Mini-Mental State Examination at 36 months, Clinical Dementia Rating Scale Sum of Boxes at 36 months and 4 more. Started Oct 2025; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06896201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06896201.